Brent Saunders

Chairman, President & CEO
Allergan plc

Brent Saunders was elected chairman in 2016, and has served as a director and as chief executive officer and president from July 2014 to May 2016. He previously served as chief executive officer and president of Forest Laboratories, Inc. and served as a director of Forest beginning in 2011. Saunders has significant healthcare industry expertise and a proven track-record leading business transformations and integrations. Prior to Forest, he served as chief executive officer of Bausch + Lomb Incorporated, a leading global eye health company, serving in this capacity from March 2010 until August 2013. Saunders also held a number of leadership positions at Schering-Plough, including the position of president of global consumer health care and was named head of integration for the company’s merger with Merck & Co. and for Schering-Plough’s acquisition of Organon BioSciences. Before joining Schering-Plough, Saunders was a partner and head of compliance business advisory at PricewaterhouseCoopers LLP. Prior to that, he was chief risk officer at Coventry Health Care and senior vice president, compliance, legal and regulatory at Home Care Corporation of America. Saunders began his career as chief compliance officer for the Thomas Jefferson University Health System.

Saunders serves on the board of directors at RWJBarnabas Health and is a member of the business council and PhRMA. He received a bachelor’s degree from the University of Pittsburgh, a Master of Business Administration degree from Temple University School of Business, and a Juris doctorate from Temple University School of Law.